Treatment–period interaction 1-150 | Period effect 1-151 | Treatment effect 1-152 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Median | 95% CI | p Value | Median | 95% CI | p Value | Median | 95% CI | p Value | |||
Frequency | −0.5 | −1 to 0 | 0.22 | 1 | 0 to 2 | 0.1 | 0 | 0 to 1 | 0.47 | ||
Average duration | 0 | −0.5 to 0 | 0.35 | 0 | 0 to 1 | 0.5 | 0 | 0 to 1 | 0.31 | ||
Total duration | −0.5 | −1 to 0.5 | 0.29 | 0 | 0 to 3 | 0.33 | 0 | −1 to 2 | 0.51 | ||
TEC | −181 | −565 to 56 | 0.18 | 52 | −142 to 334 | 0.55 | −123 | −362 to 135 | 0.14 |
↵1-150 For the treatment–period interaction, negative numbers represent an improvement on sotalol followed by atenolol, and positive numbers represent an improvement on atenolol followed by sotalol.
↵1-151 For the period effect, negative numbers represent an improvement towards the beginning of the trial and positive numbers an improvement towards the end of the trial.
↵1-152 For the effect of treatment, negative numbers represent an improvement on sotalol, and positive numbers an improvement on atenolol.
CI, confidence interval; TEC, total ectopic count.